tb4 frag vs bpc 157 BPC-157 + TB4-Frag bpc 157 tb4 frag Peptide

Sikiric, P., Seiwerth, S., Grabarevic, Z., Rucman, R., Petek, M., Jagic, V., Turkovic, B., Rotkvic, I., Mise, S., Zoricic, I., Konjevoda, P., Perovic, D., Simicevic, V., Separovic, J., Hanzevacki, M., Ljubanovic, D., Artukovic, B., Bratulic, M., Tisljar, M., & Rekic, B

People should avoid self-administering medications into the dorsogluteal muscles

Peptides require metabolic support, adequate protein intake, and consistent use to take effect

1984 Feb;63(2):335-41

Thanks to its cytoprotective effects in the GI tract , BPC-157 is being explored as a therapy for inflammatory bowel diseases like Crohns disease and ulcerative colitis